Jim O’Neill steps in as acting CDC director, replacing Susan Monarez amid controversy over vaccine policies. With ties to RFK Jr. and a libertarian stance, will he advocate for public health or follow orders?
The Trump administration faces rare bipartisan backlash after the firing of CDC Director Susan Monarez, leading to protests at the agency and concerns over vaccine access and public health.
In a surprising turn of events, Jim O'Neill has been appointed as the interim director of the CDC following a high-profile dispute involving former director Susan Monarez. What does this mean for public health?
In a dramatic turn of events, Health Secretary Robert F. Kennedy Jr. confronts CDC Director Susan Monarez, demanding she fire agency officials or face termination herself. The standoff has paralyzed the CDC amid ongoing turmoil.
In a dramatic shakeup, Jim O'Neill has been appointed as the acting director of the CDC following the ousting of Susan Monarez. This transition comes amidst widespread resignations and controversy surrounding the agency's leadership and vaccine policies.
In a dramatic shift, CDC Director Susan Monarez was fired after opposing controversial vaccine policies pushed by Health Secretary Robert F. Kennedy Jr. This upheaval raises critical questions about U.S. public health strategies.
A horrific mass shooting at Annunciation Catholic School in Minneapolis left two children dead and 17 others injured during a morning mass. The FBI has launched an investigation into the incident as a hate crime targeting Catholics.
In a surprising turn of events, CDC Director Susan Monarez has resigned just weeks into her new role, following a series of controversial vaccine policy changes and workforce layoffs, sparking widespread concern among public health experts.
In a surprising development, CDC Director Susan Monarez was ousted merely weeks after her Senate confirmation, following pressures related to vaccine policy changes advocated by RFK Jr.
The CDC has a new director, Susan Monarez, confirmed by the Senate after months of turmoil. As the first non-medical director in over 70 years, she faces the challenge of restoring trust and navigating a chaotic agency.
